Ann Lab Med.  2012 Sep;32(5):359-361. 10.3343/alm.2012.32.5.359.

Multiplex PCR for Rapid Detection of Genes Encoding Class A Carbapenemases

Affiliations
  • 1Department of Laboratory Medicine, CHA Bundang Medical Center, CHA University, Seongnam, Korea. hlseo@cha.ac.kr
  • 2Department of Laboratory Medicine, CHA Gumi Medical Center, CHA University, Gumi, Korea.

Abstract

In recent years, there have been increasing reports of KPC-producing Klebsiella pneumoniae in Korea. The modified Hodge test can be used as a phenotypic screening test for class A carbapenamase (CAC)-producing clinical isolates; however, it does not distinguish between carbapenemase types. The confirmation of type of CAC is important to ensure optimal therapy and to prevent transmission. This study applied a novel multiplex PCR assay to detect and differentiate CAC genes in a single reaction. Four primer pairs were designed to amplify fragments encoding 4 CAC families (SME, IMI/NMC-A, KPC, and GES). The multiplex PCR detected all genes tested for 4 CAC families that could be differentiated by fragment size according to gene type. This multiplex PCR offers a simple and useful approach for detecting and distinguishing CAC genes in carbapenem-resistant strains that are metallo-beta-lactamase nonproducers.

Keyword

Carbapenemase; Multiplex PCR; KPC; GES

MeSH Terms

Bacterial Proteins/*genetics/metabolism
DNA Primers/metabolism
Databases, Genetic
Humans
Klebsiella Infections/microbiology
Klebsiella pneumoniae/genetics/isolation & purification/metabolism
*Multiplex Polymerase Chain Reaction
beta-Lactamases/*genetics/metabolism

Figure

  • Fig. 1 Results of multiplex PCR for class A carbapenemase (CAC)-producing strains. Multiplex PCR products were separated on a 2% agarose gel. Lanes 1 and 14 show the 100-bp DNA ladder; lane 2, the PCR product of the negative control (distilled water); lanes 3 and 4, KPC-type enzyme-producing strains; lane 5, SME-type; lanes 6 and 7, NMC-A and IMI-type, respectively; lanes 8-13, GES-type. The amplified product from each PCR is indicated on the right, and the size of the marker in base pairs is shown on the left.


Reference

1. Patel G, Bonomo RA. Status report on carbapenemases: challenges and prospects. Expert Rev Anti Infect Ther. 2011. 9:555–570.
Article
2. Gupta N, Limbago BM, Patel JB, Kallen AJ. Carbapenem-resistant Enterobacteriaceae: epidemiology and prevention. Clin Infect Dis. 2011. 53:60–67.
3. Miriagou V, Cornaglia G, Edelstein M, Galani I, Giske CG, Gniadkowski M, et al. Acquired carbapenemases in Gram-negative bacterial pathogens: detection and surveillance issues. Clin Microbiol Infect. 2010. 16:112–122.
Article
4. Cornaglia G, Rossolini GM. The emerging threat of acquired carbapenemases in Gram-negative bacteria. Clin Microbiol Infect. 2010. 16:99–101.
Article
5. Ambretti S, Gaibani P, Caroli F, Miragliotta L, Sambri V. A carbapenem-resistant Klebsiella pneumoniae isolate harboring KPC-1 from Italy. New Microbiol. 2010. 33:281–282.
6. Villegas MV, Lolans K, Correa A, Kattan JN, Lopez JA, Quinn JP. First identification of Pseudomonas aeruginosa isolates producing a KPC-type carbapenem-hydrolyzing β-lactamase. Antimicrob Agents Chemother. 2007. 51:1553–1555.
7. Wei ZQ, Du XX, Yu YS, Shen P, Chen YG, Li LJ. Plasmid-mediated KPC-2 in a Klebsiella pneumoniae isolate from China. Antimicrob Agents Chemother. 2007. 51:763–765.
8. Yigit H, Queenan AM, Anderson GJ, Domenech-Sanchez A, Biddle JW, Steward CD, et al. Novel carbapenem-hydrolyzing β-lactamase, KPC-1, from a carbapenem-resistant strain of Klebsiella pneumoniae. Antimicrob Agents Chemother. 2001. 45:1151–1161.
9. Rhee JY, Park YK, Shin JY, Choi JY, Lee MY, Peck KR, et al. KPC-producing extreme drug-resistant Klebsiella pneumoniae isolate from a patient with diabetes mellitus and chronic renal failure on hemodialysis in South Korea. Antimicrob Agents Chemother. 2010. 54:2278–2279.
10. Roh KH, Lee CK, Sohn JW, Song W, Yong D, Lee K. Isolation of a Klebsiella pneumoniae isolate of sequence type 258 producing KPC-2 carbapenemase in Korea. Korean J Lab Med. 2011. 31:298–301.
11. Thomson KS. Extended-Spectrum-β-Lactamase, AmpC, and Carbapenemase issues. J Clin Microbiol. 2010. 48:1019–1025.
Article
12. Pasteran F, Mendez T, Guerriero L, Rapoport M, Corso A. Sensitive screening tests for suspected class A carbapenemase production in species of Enterobacteriaceae. J Clin Microbiol. 2009. 47:1631–1639.
13. Girlich D, Poirel L, Nordmann P. Novel ambler class A carbapenem-hydrolyzing β-lactamase from a Pseudomonas fluorescens isolate from the Seine River, Paris, France. Antimicrob Agents Chemother. 2010. 54:328–332.
14. Henriques I, Moura A, Alves A, Saavedra MJ, Correia A. Molecular characterization of a carbapenem-hydrolyzing class A β-lactamase, SFC-1, from Serratia fonticola UTAD54. Antimicrob Agents Chemother. 2004. 48:2321–2324.
Full Text Links
  • ALM
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2024 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr